Sakae Asanuma, Director, 10% Owner at Werewolf Therapeutics, Inc. (HOWL), bought 1,630,811 shares at $16.00 ($5.0M) on 2021-05-04, disclosed to the SEC on 2021-05-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,318,311 | $0 | 0.0% |
| 2 | $16.00 | 312,500 | $5.0M | 100.0% |
| Total | $3.07 avg | 1,630,811 | $5.0M | 100% |